Altai Enkhbayar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Altai Enkhbayar has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Alexandria N. Brown
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
1 shared publication- Amin Majid Alousi
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
1 shared publication - Aqsa Mohammed
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
1 shared publication - Ashish Damania
Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA
1 shared publication Cesar A. Arias
Department of Medicine, Weill Cornell Medical College, New York, NY
1 shared publication- Chia-Chi Chang
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
1 shared publication
Latest Publications
- Open Access
- 13 March 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (6) , 1979-1991
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD
Lower gastrointestinal graft-versus-host disease (LGI-GVHD) carries morbidity and mortality for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with critical contributions from the intestinal microbiome. In a retrospective cohort of metagenomic sequencing of stool from patients with allo-HSCT (N = 90), we found that a reduction in specific Parabacteroides and Bacteroides species around the time of engraftment contributes to LGI-GVHD risk. Given the known diverse carbohydrate-degrading functionality of these bacteria, we investigated gene abundances for carbohydrate-active enzymes (CAZymes) and found that Parabacteroides merdae, P distasonis, and Bacteroides ovatus abundances were significantly correlated with CAZymes in patients who did not develop LGI-GVHD compared with those who did. The specific gene abundances of xylosidase, which contribute to the degradation of xylose-containing polysaccharides, were significantly associated with a reduced risk of LGI-GVHD. All these findings show the importance of the carbohydrate-degrading functionality of putative beneficial bacteria in mediating risk of LGI-GVHD.
- 13 March 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (6) , 1979-1991
Open AccessFecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD
Lower gastrointestinal graft-versus-host disease (LGI-GVHD) carries morbidity and mortality for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with critical contributions from the intestinal microbiome. In a retrospective cohort of metagenomic sequencing of stool from patients with allo-HSCT (N = 90), we found that a reduction in specific Parabacteroides and Bacteroides species around the time of engraftment contributes to LGI-GVHD risk. Given the known diverse carbohydrate-degrading functionality of these bacteria, we investigated gene abundances for carbohydrate-active enzymes (CAZymes) and found that Parabacteroides merdae, P distasonis, and Bacteroides ovatus abundances were significantly correlated with CAZymes in patients who did not develop LGI-GVHD compared with those who did. The specific gene abundances of xylosidase, which contribute to the degradation of xylose-containing polysaccharides, were significantly associated with a reduced risk of LGI-GVHD. All these findings show the importance of the carbohydrate-degrading functionality of putative beneficial bacteria in mediating risk of LGI-GVHD.